




版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Primarybloodstreaminfectionasanindication:RegulatoryperspectiveFDA/IDSA/ISAPWorkshopApril15,2004DavidRoss,M.D.,Ph.D.1OutlineRegulatoryhistoryDefininganti-infective(AI)indicationsPrimarybloodstreaminfectionasanAIindication2Bloodstreaminfection(BSI):history10drugsindicatedforbacteremiaorsepticemiaAlllabeledpriorto1992LabelingbasedonvariableorunspecifiedclinicalmanifestationsindifferentstudiesIncludesbacteremiaassociatedwithfocalinfectionandbacteremiaofunknownoriginPatientspooledfromtrialsofotherindications39/93Anti-InfectiveDrugsACmeetingBacteremiadidnotaffectoutcomeinalargeNDAdatasetBacteremiaisduetoinfectionataprimarysiteBacteremicSIRSpatientsformaheterogeneouspopulationUnclearifbacteremicSIRSpatientsweresickerthannonbacteremicpatients49/93ACconclusionsBacteremialessimportantthansiteofinfectionforclassifyinginfectionsStudyof‘bacteremicsepsis’asaseparateindicationnotfeasiblegivenheterogeneityofpatientpopulationLabelingshouldincludebacteremiainthecontextofsite-specificinfections,e.g.,“pneumoniawithassociatedbacteremia”5ReconsideringBSIasanindicationIncreasedincidenceofBSI:withresistantpathogens(e.g.,VRE,MRSA)withoutidentifiableprimarysourceIssuesinmeasuringdrugeffectinBSI...PatientheterogeneityDifferencesinnaturalhistoryfordifferentpathogensDifferencesinpathogenepidemiology/virulenceNeedtodefineanidentifiableclinicalsyndrome ...beforeconsideringasanindication6Doesbacteremiaequaldestiny?28yofemalewithpatchyinfiltrateinonelobe.Nocomorbidities.HR80,RR16.SCx
→
S.pneumoniaeBCx→
S.pneumoniae.Mortalityrisk<0.1%52yomalewithmultilobarpneumonia.Chronicrenalfailure,uncontrolledDMHR130,RR35.Intubated.SCx
→
S.pneumoniaeBCx→negativeMortalityrisk27%
7NotallbacteremiasarethesameA76yonursinghomeresidentwasadmittedforalteredmentalstatus,hypotension,hypo-thermia,obtundation,andneckstiffness.ACXRshowedbi-lateralinfiltrates.AnLPshowed4,218WBC/μL(89%segs)andglucoseoflessthan20mg/dL.BloodandCSFCxgrewMRSA. DespiteMICUtransfer,therapywithvancomycinandrifampin,andaggressivesupportivecare,thepatientdeterioratedanddied11daysafteradmission.A67yoMwithchronicrenalfailurereceivinghemodialysisviaanarteriovenousgraftwasadmit-tedforfeverto38.0°C;thepatientwasotherwisewell.Nomurmurwasfoundandthegraftwasnon-tender.Thefeverresolvedandvancomycinwasstarted.BCxgrewMRSA.Therewasnofurtherfeverorothersx.ArepeatBCxwaspositive.Atransesophageal
echocardio-gramwasnegative,aswasaDopplerultrasoundofthegraft.Thepatientreceived4weeksofIVvancomycinanddidwell.RepeatBCxwerenegative.8Site-basedanti-infective(AI)indication“Infectionataspecifiedbodysiteduetoaspecified,susceptiblemicroorganism”.(PointstoConsider,1992)AccountsfordifferencesindrugefficacyforinfectionsatdifferentsitesAllowsdemonstrationofefficacyfromadequateandwell-controlledstudiesAllowsdescriptionofdrugeffectinlabeling9EssentialsofanAIindicationMustbearecognizeddiseaseorcondition,oranimportantmanifestationofadiseaseDefinablesyndromewithspecificclinicalmanifestations,diagnosticcriteria,andtherapeuticrequirementsDrugtreatmenteffectdemonstrableviaadequateandwell-controlledtrialsusingclinicallyrelevantendpointsDescribableinlabeling10AIindicationsvs.non-indicationsAIindicationsUrinarytractinfectionOsteomyelitisBacterialmeningitisStreptococcalpharyngitisCommunity-acquiredpneumoniaProphylaxisagainstpost-operativeinfectionNon-indicationsDysuriaElevatedESRComathroatcultureforGASPleuriticchestpainDecreaseinskincolonization11CAPUTIBacteremiaMeningitisEndocarditisComplicatedIABDOsteomyelitisSSTI12BSIvs.bacteremiaCandidalBSI(candidemia)AcceptedAIindicationFrequentlyprimaryBSI(noidentifedunderlyinginfection)DefinableclinicalsyndromeEscherichiacolibacteremiaNotacceptedAIindicationVirtuallyneverprimaryBSIVarietyofpotentialunderlyinginfections(e.g.,GI,GU)Varietyofclinicalmanifestations13BSIvs.(pseudo)bacteremiaPeripheralBCx(n=1408)CatheterBCx(n=1408)pvalueTrueBSI13.7%14.4%0.59Contamination1.8%3.8%0.001Indeterminate0.9%1.6%0.09Negative83.6%80.1%0.02EvertsRJetal.JClinMicrobiol.2001;39:3393-339414BacteremiaasasurrogateendpointChaissonRetal.Ann.Intern.Med.1994;121:905-11Clarithromycindose500mgbid1000mgbid2000mgbidBacterialloadat2weeks(cfu/mL)1453425Mortalityat12weeks5.7%25.5%28.0%15QuestionsIsthereadistinctpatientpopulationwithprimarybacterialBSIthatcanbeidentifiedatthetimeofrandomizationintoaclinicaltrial?Ifyes,howshouldpatientswithbacterialBSIwhodemonstrateevidenceofmetastaticinfectionpost-randomizationbeclassifiedwithregardtoa)whethertheBSIwasprimaryorsecondaryatthetimeofrandomization;b)outcome?W
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025届河南省三门峡市化学高一下期末复习检测模拟试题含解析
- 内蒙古自治区赤峰市2025年高二化学第二学期期末综合测试模拟试题含解析
- 桐柏危房排查管理办法
- 杭州电子印章管理办法
- 材料命名规则管理办法
- 村级厕所后期管理办法
- 填料技术创新方向-洞察及研究
- 医保应急账户管理办法
- 废旧锂离子电池回收处理综合利用项目的环境保护评估报告
- 河源住房维修管理办法
- GB/T 20319-2017风力发电机组验收规范
- GB/T 18391.4-2009信息技术元数据注册系统(MDR)第4部分:数据定义的形成
- GB/T 13017-2018企业标准体系表编制指南
- 蒸汽锅炉的对比分析
- 038正式送电申请单
- 医学课件-快速康复ERAS普外科幻灯教学课件
- 关联交易同期资料培训讲义课件
- 压力管道基础知识(管理类)
- 气体灭火系统验收表1
- 新北师大版六年级上册数学全册教学课件
- DB1309T 256-2021 榆三节叶蜂综合防治技术规程
评论
0/150
提交评论